Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Tumor Profiling Market, Technique
7.1. Tumor Profiling Market, Technique, 2021-2028
7.1.1. Genomics
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Proteomics
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Metabolomics
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Epigenetics
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Tumor Profiling Market, By Application
8.1. Tumor Profiling Market, by Application, 2021-2028
8.1.1. Personalized Medicine
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Oncological Diagnostics
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Research
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Tumor Profiling Market, Technology
9.1. Tumor Profiling Market, Technology, 2021-2028
9.1.1. Sequencing Techniques
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. In Situ Hybridization
9.1.2.1. Market Revenue and Forecast (2016-2028)
9.1.3. Immunohistochemistry
9.1.3.1. Market Revenue and Forecast (2016-2028)
9.1.4. qPCR
9.1.4.1. Market Revenue and Forecast (2016-2028)
9.1.5. Microarray
9.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Tumor Profiling Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, Technique (2016-2028)
10.1.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.3. Market Revenue and Forecast, Technology (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, Technique (2016-2028)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.4.3. Market Revenue and Forecast, Technology (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, Technique (2016-2028)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.5.3. Market Revenue and Forecast, Technology (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, Technique (2016-2028)
10.2.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.3. Market Revenue and Forecast, Technology (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, Technique (2016-2028)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.4.3. Market Revenue and Forecast, Technology (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, Technique (2016-2028)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.5.3. Market Revenue and Forecast, Technology (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, Technique (2016-2028)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.6.3. Market Revenue and Forecast, Technology (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, Technique (2016-2028)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.7.3. Market Revenue and Forecast, Technology (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, Technique (2016-2028)
10.3.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.3. Market Revenue and Forecast, Technology (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, Technique (2016-2028)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.4.3. Market Revenue and Forecast, Technology (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, Technique (2016-2028)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.5.3. Market Revenue and Forecast, Technology (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, Technique (2016-2028)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.6.3. Market Revenue and Forecast, Technology (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, Technique (2016-2028)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.7.3. Market Revenue and Forecast, Technology (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, Technique (2016-2028)
10.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.3. Market Revenue and Forecast, Technology (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, Technique (2016-2028)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.4.3. Market Revenue and Forecast, Technology (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, Technique (2016-2028)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.5.3. Market Revenue and Forecast, Technology (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, Technique (2016-2028)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.6.3. Market Revenue and Forecast, Technology (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, Technique (2016-2028)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.7.3. Market Revenue and Forecast, Technology (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, Technique (2016-2028)
10.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.3. Market Revenue and Forecast, Technology (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, Technique (2016-2028)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.4.3. Market Revenue and Forecast, Technology (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, Technique (2016-2028)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.5.3. Market Revenue and Forecast, Technology (2016-2028)
Chapter 11. Company Profiles
11.1. Illumina Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Qiagen N.V.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Genomic Health
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Neogenomics Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. HTG Molecular Diagnostics, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Caris Life Sciences
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Helomics Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Oxford Gene Technology
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Nanostring Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ribomed Biotechnologies Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. GenomeDX
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Guardant Health
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Foundation Medicine.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms